Immunological consequences from exposure to benzo(a)pyrene during pregnancy

Scand J Immunol Suppl. 1992:11:203-6. doi: 10.1111/j.1365-3083.1992.tb01653.x.

Abstract

Progeny and maternal immune status after benzo(a)pyrene (BP) exposure of mothers at mid-pregnancy is disrupted in fetal liver (FL), in spleen and in thymus during pregnancy and postnatally. Mice suffer deficiencies in splenic and thymic mixed lymphocyte responses (MLR), and disorientations of T antigen expressing cells, punctuated by exorbitant increases in Lyt2, especially in FL. FL Lyt2 do not suppress an MLR, while Lyt1 mediate suppression. Isolated Thy1 show a weak response to Concanavalin A; FL Thy1 weakly express an MLR. Maternal macrophages and progeny B cells are also functionally abnormal. Thus, BP induces generalized immune deficiency that may affect ontogeny and which is potentially deleterious to health.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzo(a)pyrene / toxicity*
  • Female
  • Fetus / drug effects*
  • Immunity / drug effects*
  • Mice
  • Mice, Inbred C3H
  • Pregnancy
  • Pregnancy, Animal / drug effects*

Substances

  • Benzo(a)pyrene